The Impact of Atorvastatin on Prostate Cancer - a Randomized, Pre-surgical Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 14 May 2018
At a glance
- Drugs Atorvastatin (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- Acronyms ESTO1
- 04 May 2018 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 29 Nov 2016 Planned End Date changed from 1 Aug 2016 to 1 Aug 2017.